Guangsheng Zhao
Overview
Explore the profile of Guangsheng Zhao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
87
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li G, Du H, Yan Y, Hou Y, Zhao G, Lei X, et al.
BMC Musculoskelet Disord
. 2025 Mar;
26(1):221.
PMID: 40045257
Objective: To evaluate the effectiveness of using dorsal toe fibula composite flaps and iliac bone in sequential transplantation for the comprehensive reconstruction of fingers with grade I to III defects....
2.
Liu S, Liu C, Wang Q, Liu Y, Wang D, Zhao G, et al.
Ir J Med Sci
. 2024 Feb;
193(3):1215-1222.
PMID: 38300460
Background: This study aimed to investigate the efficacy and safety of CalliSpheres drug-eluting beads transarterial chemoembolization (DEB-TACE) combined with regorafenib in the second-line treatment of unresectable hepatocellular carcinoma. Methods: A...
3.
Deng Y, Zhao G, Cheng K, Shi C, Xiao G
Foods
. 2023 Apr;
12(8).
PMID: 37107526
Additives can influence the processability and quality of three-dimensional (3D)-printed foods. Herein, the effects of apple polyphenols on the antioxidant activity and structure of 3D-printed processed cheese were investigated. The...
4.
Zhang Z, Chang X, Zhang W, Yang S, Zhao G
J Atten Disord
. 2023 Feb;
27(6):583-597.
PMID: 36803119
Objective: This study aims to perform a systematic review and meta-analysis of the effect of MBIs (Mindfulness, Tai Chi, Yoga, and Qigong) on symptoms and executive function (EF) in ADHD....
5.
Su M, Chen S, Li S, Xu F, Zhao G, Qu J, et al.
J Gastrointest Oncol
. 2023 Jan;
13(6):3183-3192.
PMID: 36636092
Background: The treatment of advanced hepatocellular carcinoma (HCC) is challenging. The positive effect of gelatin sponge microparticles for transarterial chemoembolization (GSMs-TACE) in the treatment of Barcelona Clinic Liver Cancer (BCLC)...
6.
Zhao G, Bi M, Liu S, Ma J, Xu F, Liu Y, et al.
Scand J Clin Lab Invest
. 2022 Nov;
82(7-8):549-555.
PMID: 36344035
Immune environment plays an important role in the management of liver cancer. The current study aimed to explore the change of NK and NKT cells, IL-17A, CD4 T and CD8...
7.
Zhao G, Liu S, Liu Y, Li X, Yu G, Zhang Y, et al.
Front Oncol
. 2022 Aug;
12:882061.
PMID: 36033546
Objective: Poor prognosis and limited treatments of liver metastases from non-small-cell lung cancer (NSCLC) after radical surgery are critical issues. The current study aimed to evaluate the efficacy and safety...
8.
Liu S, Yu G, Wang Q, Li L, Liu Y, Du K, et al.
Am J Transl Res
. 2022 Jan;
13(12):13931-13940.
PMID: 35035734
Purpose: To explore the clinical efficacy and safety of CalliSpheres microspheres drug-eluting bead transarterial chemoembolization (DEB-TACE) combined with sorafenib in the treatment of large liver cancer. Method: The study retrospectively...
9.
Zhao G, Liu S, Zhang Y, Zhao T, Wang R, Bian J, et al.
Ir J Med Sci
. 2021 Jul;
191(3):1139-1145.
PMID: 34264426
Background: Callispheres® microspheres (CSM) are the first drug-eluting bead (DEB) product developed in China; meanwhile, DEB-transarterial chemoembolization (TACE) with CSM is effective and safe in the treatment of hepatocellular carcinoma...
10.
Zhao G, Liu S, Chen S, Ren Z, Li C, Bian J, et al.
Drug Deliv
. 2021 Jun;
28(1):1356-1362.
PMID: 34180755
This study aimed to compare efficacy and safety of HepaSpheres and CalliSpheres in unresectable large hepatocellular carcinoma (HCC) patients. One hundred and twenty-seven unresectable large HCC patients receiving drug-eluting bead...